Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Leukoc Biol ; 74(5): 942-51, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12960242

RESUMEN

Leukocytosis in tobacco smokers has been well recognized; however, the exact cause has not been elucidated. To test the hypothesis that tobacco nicotine stimulates neutrophils in the respiratory tract to produce IL-8, which causes neutrophilia in vivo, we examined whether nicotine induces neutrophil-IL-8 production in vitro; the causative role of NF-kappaB in its production, in association with the possible production of reactive oxygen intermediates that activate NF-kappaB; and the nicotinic acetylcholine receptors (nAChRs) involved in IL-8 production. Nicotine stimulated neutrophils to produce IL-8 in both time- and concentration-dependent manners with a 50% effective concentration of 1.89 mM. A degradation of IkappaB-alpha/beta proteins and an activity of NF-kappaB p65 and p50 were enhanced following nicotine treatment. The synthesis of superoxide and the oxidation of dihydrorhodamine 123 (DHR) were also enhanced. The NOS inhibitor, nomega-Nitro-l-arginine methyl ester, prevented nicotine-induced IL-8 production, with an entire abrogation of DHR oxidation, IkappaB degradation, and NF-kappaB activity. Neutrophils spontaneously produced NO whose production was not increased, but rather decreased by nicotine stimulation, suggesting that superoxide, produced by nicotine, generates peroxynitrite by reacting with preformed NO, which enhances the NF-kappaB activity, thereby producing IL-8. The nAChRs seemed to be involved in IL-8 production. In smokers, blood IL-8 levels were significantly higher than those in nonsmokers. In conclusion, nicotine stimulates neutrophil-IL-8 production via nAChR by generating peroxynitrite and subsequent NF-kappaB activation, and the IL-8 appears to contribute to leukocytosis in tobacco smokers.


Asunto(s)
Interleucina-8/sangre , FN-kappa B/sangre , Neutrófilos/inmunología , Nicotina/farmacología , Ácido Peroxinitroso/sangre , Humanos , Proteínas I-kappa B/sangre , Interleucina-8/biosíntesis , Cinética , Inhibidor NF-kappaB alfa , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/biosíntesis , Peroxidasa/sangre , Transporte de Proteínas , Especies Reactivas de Oxígeno/metabolismo , Fumar/sangre , Factor de Necrosis Tumoral alfa/farmacología
2.
J Leukoc Biol ; 72(5): 1011-9, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12429724

RESUMEN

Human plasmacytoid or CD4(+)CD11c(-) type 2 dendritic cell precursors (PDC) were identified as natural type I interferon (IFN)-producing cells in response to viral and bacterial infection. They represent effector cells of innate immunity and link it to the distinct adaptive immunity by differentiating into mature DC. It has been reported that oligodeoxyribonucleotides containing unmethylated CpG motifs (CpG DNA) stimulate PDC to produce IFN-alpha, but the molecular mechanisms involved remain unknown. We found that CpG-DNA-induced IFN-alpha production in PDC was completely impaired by the inhibitor of the p38 mitogen-activated protein kinase (MAPK) pathway. Expression of IFN regulatory factor (IRF)-7 was enhanced by CpG-DNA treatment, which was preceded by the phosphorylation of signal transducer and activator of transcription (STAT)1 on Tyr-701, as well as its enhanced phosphorylation on Ser-727. All of these events were also suppressed by the p38 MAPK inhibitor. STAT1, STAT2, and IRF-9, components of IFN-stimulated gene factor 3 (ISGF3), were recognized in the nuclear fraction of CpG-DNA-treated cells. Neither anti-IFN-alpha/beta antibodies (Ab) nor anti-IFNAR Ab suppressed STAT1 phosphorylation, enhancement of IRF-7 expression, or IFN-alpha production in the early phase of the culture. These results suggest that CpG DNA induces p38 MAPK-dependent phosphorylation of STAT1 in a manner independent of IFN-alpha/beta, which may cause ISGF3 formation to increase the transcription of the IRF-7 gene, thereby leading to IFN-alpha production in human PDC.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Células Dendríticas/inmunología , Interferón-alfa/biosíntesis , Proteínas Quinasas Activadas por Mitógenos/fisiología , Oligodesoxirribonucleótidos/farmacología , Transactivadores/metabolismo , Núcleo Celular/química , Células Cultivadas , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/química , Regulación de la Expresión Génica , Humanos , Factor 3 Regulador del Interferón , Factor 7 Regulador del Interferón , Factor 3 de Genes Estimulados por el Interferón , Subunidad gamma del Factor 3 de Genes Estimulados por el Interferón , Interferón-alfa/genética , Cinética , Modelos Inmunológicos , Fosforilación , ARN Mensajero/biosíntesis , Factor de Transcripción STAT1 , Factor de Transcripción STAT2 , Serina/metabolismo , Células Madre/efectos de los fármacos , Células Madre/inmunología , Transactivadores/análisis , Transactivadores/química , Factores de Transcripción/análisis , Factores de Transcripción/biosíntesis , Tirosina/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos
3.
J Comp Neurol ; 449(4): 330-42, 2002 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-12115669

RESUMEN

Microtubule-associated protein 2 (MAP2) occurs in developing mammalian neuronal tissue as both high- and low-molecular-weight forms with temporally regulated expression. We studied the MAP2 expression in the developing rat telencephalon with monoclonal antibodies that recognized both the high- and low-molecular-weight forms of MAP2 variants or that specifically recognized high-molecular-weight forms of MAP2 variants. Differences in the staining patterns of these antibodies reflected differences in the distribution of the high- and low-molecular-weight MAP2s. The immunoreactive sites of high- and low-molecular-weight MAP2 had a more widespread distribution in the embryonic telencephalon than those of high-molecular-weight MAP2. Many bipolar cells in the ganglionic eminence (GE) and in the intermediate zone (IZ) of the neocortex showed low-molecular-weight MAP2 immunoreactivity, but they showed weak or no high-molecular-weight MAP2 immunoreactivity. Expression of mRNA containing exons common to high- and low-molecular-weight MAP2 was detected in the tangentially ellipsoidal cells in the IZ, but expression of mRNA containing an exon specific to high-molecular-weight MAP2 was not detected in these cells by in situ hybridization. We interpreted these observations as indicating that the bipolar cells contained MAP2c preferentially, but contained MAP2a and MAP2b (MAP2a/b) at a very low or negligible level. The cells that expressed MAP2c preferentially among the MAP2 splicing variants composed 50% of the preplate cells, most of the MAP2-positive cells in the hippocampus and the corpus callosum. Double labeling by DiI staining and Dlx2 immunohistochemistry, or by Dlx2 and MAP2 immunohistochemistry, revealed that most of the Dlx2-positive cells in the IZ expressed MAP2c preferentially at embryonic day 16. Another double-labeling study revealed that most GAD-positive cells in the preplate were MAP2a/b positive, whereas most GAD-positive cells in the IZ expressed MAP2c preferentially, with only a negligible level of MAP2a/b immunoreactivity. We conclude that MAP2 immunoreactivity in the IZ was localized in the tangentially migrating neurons. The tangentially migrating neurons seemed to acquire MAP2a/b immunoreactivity as they entered the preplate or cortical plate and developed into mature neurons. Radially migrating neurons in the IZ were MAP2 negative. After entering to the preplate or the cortical plate, they became MAP2a/b positive as they developed into mature neurons.


Asunto(s)
Proteínas Asociadas a Microtúbulos/metabolismo , Telencéfalo/embriología , Telencéfalo/metabolismo , Animales , Anticuerpos Monoclonales/análisis , Diferenciación Celular/fisiología , Embrión de Mamíferos , Femenino , Inmunohistoquímica , Ratones , Proteínas Asociadas a Microtúbulos/análisis , Proteínas Asociadas a Microtúbulos/biosíntesis , Peso Molecular , Neuronas/química , Neuronas/citología , Neuronas/metabolismo , Embarazo , Isoformas de Proteínas/análisis , Isoformas de Proteínas/biosíntesis , Isoformas de Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Telencéfalo/química , Telencéfalo/citología
4.
J Comp Neurol ; 455(2): 238-48, 2003 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-12454988

RESUMEN

The ganglionic eminence (GE) supplies neurons containing gamma-aminobutyric acid (GABA) to the pallium of the telencephalon. We investigated the molecular guidance mechanisms of GE cell migration in the neocortex and found neuropilin-1 (Npn-1) or neuropilin-2 (Npn-2) on the GE cells. Ectopic Sema3A or -3F expression by COS1 cell clusters placed on embryo neocortical slices reduced the cell migration but did not block it completely. However, the cell migration was almost completely blocked by COS1 cell clusters expressing both Sema3A and -3F. The direction of cell migration could be reversed by placing Sema3A- and -3F-coexpressing COS1 cell clusters at the distal cut end of the neocortical slices. Further slice experiments revealed that migration of half of the GE cells in the neocortex was regulated by Sema3A and that migration of the other half of the GE cells in the neocortex was regulated by Sema3F. When the cells responding to Sema3A were diverted by ectopic Sema3A expression in vivo, Dlx2-positive cells were found predominantly in the lower intermediate zone (IZ). When the cells responding to Sema3F were diverted by ectopic Sema3F expression in vivo, Dlx2-positive cells were found predominantly in the upper IZ. It was speculated that the semaphorin-neuropilin interactions distribute the GABAergic GE cells evenly in the neocortex as well as guide the GE cells from the GE to the neocortex. The Sema3A expression site under the subplate extended dorsally as the embryo developed. The Sema3A expression seemed to block the Npn-1-positive GE cells in the neocortex from entering the cortical plate (CP) and guide them to the dorsal cortex and the hippocampus. Sema3F expression in the CP continued through the embryonic stages. The expression seemed to block Npn-2-positive GE cells in the neocortex from entering the CP and make them migrate into the lower IZ. Finally, the semaphorin-neuropilin interactions sorted GABAergic inteneurons into the CP and white matter neurons into the IZ.


Asunto(s)
Movimiento Celular/fisiología , Proteínas de Homeodominio , Proteínas de la Membrana/genética , Neocórtex/embriología , Proteínas del Tejido Nervioso/genética , Neuronas/fisiología , Semaforina-3A/genética , Ácido gamma-Aminobutírico/metabolismo , Animales , Células COS , Proteínas del Citoesqueleto , Proteínas de Unión al ADN/biosíntesis , Embrión de Mamíferos , Regulación del Desarrollo de la Expresión Génica , Inmunohistoquímica , Hibridación in Situ , Proteínas de la Membrana/metabolismo , Neocórtex/citología , Proteínas del Tejido Nervioso/metabolismo , Neuronas/citología , Neuropilina-1/biosíntesis , Neuropilina-2/biosíntesis , Proteínas de Unión al ARN , Ratas , Ratas Sprague-Dawley , Semaforina-3A/metabolismo , Factores de Transcripción , Transfección
5.
Jpn J Infect Dis ; 55(2): 37-44, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12082305

RESUMEN

DNA containing an unmethylated CpG motif has a potent immunostimulatory effect on the vertebrate immune system. Because such CpG motifs are relatively common in bacterial DNA, but rare in mammalian animal and plant DNA, they may be an evolutionary adaptation augmenting innate immunity, most likely in response to pathogens that replicate within the host cells, such as viruses and intracellular bacteria. Microbial infection induces innate immunity by triggering pattern-recognition systems. The infected cells produce proinflammatory cytokines that directly combat microbial invaders and express costimulating surface molecules, which develop adaptive immunity by inducing distinct T cell differentiation. Bacterial DNA with unmethylated CpG-DNA stimulates vertebrate immature immune cells to induce maturation and to produce TNF-alpha as well as Th1-type cytokines, IL-12 and IFN-gamma. Therefore, CpG-DNA functions as an adjuvant for regulating the initiation of Th1 differentiation. The roles of immunostimulatory CpG motifs in DNA vaccine developments and in therapeutic applications have been discussed.


Asunto(s)
Vacuna BCG/inmunología , Islas de CpG/inmunología , ADN Bacteriano/inmunología , Tuberculosis/inmunología , Vacunas de ADN/inmunología , Adyuvantes Inmunológicos/genética , Adyuvantes Inmunológicos/farmacología , Animales , Antineoplásicos/inmunología , Secuencia de Bases , Islas de CpG/genética , ADN Bacteriano/genética , ADN Bacteriano/uso terapéutico , Humanos , Inmunización , Tuberculosis/prevención & control , Vacunas de ADN/genética
6.
J Immunol ; 177(7): 4841-52, 2006 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-16982926

RESUMEN

CpG DNA induces plasmacytoid dendritic cells (pDC) to produce type I IFN and chemokines. However, it has not been fully elucidated how the TLR9 signaling pathway is linked to these gene expressions. We examined the mechanisms involving the TLR9 and type I IFN signaling pathways, in relation to CpG DNA-induced IFN-alpha, IFN regulatory factor (IRF)-7, and chemokines CXCL10 and CCL3 in human pDC. In pDC, NF-kappaB subunits p65 and p50 were constitutively activated. pDC also constitutively expressed IRF-7 and CCL3, and the gene expressions seemed to be regulated by NF-kappaB. CpG DNA enhanced the NF-kappaB p65/p50 activity, which collaborated with p38 MAPK to up-regulate the expressions of IRF-7, CXCL10, and CCL3 in a manner independent of type I IFN signaling. We then examined the pathway through which IFN-alpha is expressed. Type I IFN induced the expression of IRF-7, but not of IFN-alpha, in a NF-kappaB-independent way. CpG DNA enabled the type I IFN-treated pDC to express IFN-alpha in the presence of NF-kappaB/p38 MAPK inhibitor, and chloroquine abrogated this effect. With CpG DNA, IRF-7, both constitutively and newly expressed, moved to the nuclei independently of NF-kappaB/p38 MAPK. These findings suggest that, in CpG DNA-stimulated human pDC, the induction of IRF-7, CXCL10, and CCL3 is mediated by the NF-kappaB/p38 MAPK pathway, and that IRF-7 is activated upstream of the activation of NF-kappaB/p38 MAPK in chloroquine-sensitive regulatory machinery, thereby leading to the expression of IFN-alpha.


Asunto(s)
Quimiocinas/biosíntesis , Islas de CpG/inmunología , Células Dendríticas/metabolismo , FN-kappa B/metabolismo , Transducción de Señal/inmunología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Western Blotting , Células Dendríticas/inmunología , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Expresión Génica , Humanos , Factor 7 Regulador del Interferón/inmunología , Factor 7 Regulador del Interferón/metabolismo , Interferón-alfa/inmunología , Interferón-alfa/metabolismo , FN-kappa B/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Receptor Toll-Like 9/inmunología , Receptor Toll-Like 9/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA